India, Feb. 5 -- image credit- freepik

Bengaluru-based MedGenome, India's leading genomics-driven diagnostics company, has announced the launch of MetaSeq, an advanced blood test designed to support faster and more comprehensive detection of bloodstream infections (BSI).

MetaSeq uses metagenomic next-generation sequencing (NGS) to analyse microbial cell-free DNA (cfDNA) present in the bloodstream. This enables identification of more than 1,400 clinically relevant pathogens in a single test, including bacteria, fungi, parasites, and DNA viruses, without the need for multiple targeted assays.

Traditionally, diagnosing bloodstream infections depends on blood culture tests that can take several days and may yield negative results if patien...